Medicine and Dentistry
Liver Transplantation
100%
Inflammatory Bowel Disease
95%
Bile Salt Export Pump
88%
COVID-19
53%
Progressive Familial Intrahepatic Cholestasis
50%
Cholestasis
44%
Acute Liver Failure
44%
Acute Hepatitis
44%
Crigler-Najjar Syndrome
44%
Crohn's Disease
44%
Severe Acute Respiratory Syndrome Coronavirus 2
44%
Enzyme Activity
44%
Bilirubin
44%
Intestinal Failure
44%
Cross Sectional Study
44%
Allogeneic Hematopoietic Stem Cell Transplantation
44%
Cystic Fibrosis
40%
Asthma
39%
Supplementation
33%
Immunosuppressive Treatment
30%
Ulcerative Colitis
27%
Adalimumab
22%
Case Presentation
22%
Crigler Najjar Syndrome Type I
22%
Gilbert's Syndrome
22%
Hyperbilirubinemia
22%
Infliximab
22%
Patient with Cystic Fibrosis
17%
Retransplantation
17%
Stem Cell Therapy
17%
Liver Graft
17%
Mucosal Disease
16%
Lateral Flow Assay
16%
Short Bowel Syndrome
16%
Recurrent Disease
15%
Emotional Stability
14%
Immunoglobulin A
12%
Case Definition
11%
Tumor Necrosis Factor
11%
Abscess
11%
Fistula
11%
Multiple Organ Dysfunction Syndrome
11%
Disease Activity
11%
Nutritional Status
11%
Insulin Dependent Diabetes Mellitus
10%
Conservative Treatment
8%
End Stage Liver Disease
8%
Immunosuppressive Drug
8%
Alloantibody
8%
Social Health
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
50%
Inflammatory Bowel Disease
47%
Hexavalent Chromium
44%
Acute Liver Failure
44%
SARS Coronavirus
44%
Toxic Injury
44%
Crigler Najjar Syndrome
44%
Acute Hepatitis
44%
Bilirubin
44%
Phenobarbital
44%
High Performance Liquid Chromatography
44%
Asthma
34%
Hyperbilirubinemia
22%
Crigler Najjar Syndrome Type I
22%
Syndrome
22%
Gilbert Disease
22%
Pandemic
15%
Arsenobetaine
14%
Methanearsonic Acid
14%
Cacodylic Acid
14%
Immunoglobulin A
12%
Multiple Organ Failure
11%
Insulin Dependent Diabetes Mellitus
9%
Seroprevalence
6%
Childhood Disease
6%
Nursing and Health Professions
Inflammatory Bowel Disease
50%
University Hospital
50%
Hospital Setting
44%
Health Care Personnel
44%
Health Outcomes
44%
Health Care Planning
44%
Severe Acute Respiratory Syndrome
44%
Cystic Fibrosis
40%
Asthma
39%
Patient with Cystic Fibrosis
17%
Pandemic
17%
Immunoglobulin A
12%
Insulin Dependent Diabetes Mellitus
10%
Childhood Disease
7%
Seroprevalence
6%
